UTI (UTI) Form 144/A: 15,000-share resale notice, awards listed
Rhea-AI Filing Summary
UTI amended a Form 144 reporting proposed sales of Common Stock on the NYSE. The filing lists 15,000 shares and a dollar figure of $536,100.00 with an effective filing date of 05/11/2026. The amendment also itemizes multiple stock awards by grant date and share counts, including awards dated 02/27/2008 (1,250), 02/22/2012 (3,682), 02/20/2013 (2,577), 04/08/2014 (3,892) and 02/27/2025 (3,599).
Positive
- None.
Negative
- None.
Insights
Amended notice for proposed sales; lists awards and aggregate figures.
The amendment identifies a proposed sale notice under Form 144/A, naming 15,000 shares and showing $536,100.00 alongside an 05/11/2026 filing date. It also lists specific stock award grant dates with share counts.
Regulatory effect: this is a reporting step to enable public resale under Rule 144 pathways; the actual timing and execution of sales are governed by Rule 144 conditions and market mechanics as applicable.
Lists compensation-related awards that underlie the resale notice.
The filing ties the shares to stock awards (labeled "Compensation") granting specific share amounts by date. Examples include 1,250 shares (02/27/2008) and 3,599 shares (02/27/2025).
These award entries explain the source of the shares being registered for resale; further details about holder identity or execution method are not provided in the excerpt.